Differential Use of Depression and Anxiety Medications in Adults With a History of Cancer

Are sociodemographic characteristics associated with antidepressant and anxiolytic use in cancer survivors?In this cross-sectional study using national data that included 5091 adult cancer survivors, non-Hispanic Black respondents had decreased odds of antidepressant use and anxiolytic use compared with non-Hispanic White cancer survivors, a significant difference. There were also significant differences by cancer type.While this study found that cancer survivors were more likely to use medication for depression and anxiety, disparities by race and ethnicity still existed in the use of these medications.

Corresponding Author: Nosayaba Osazuwa-Peters, BDS, PhD, MPH, CHES, Department of Head and Neck Surgery and Communication Sciences, Duke University School of Medicine, 40 Duke Medicine Circle, Duke South Orange Zone 4212, DUMC 3805, Durham, NC 27710-4000 (nosa.peters@duke.edu).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.